American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients

Authors

Adam Cuker, University of Pennsylvania
Kristen M Sanfilippo, Washington University School of Medicine in St. Louis
et al

Journal

Blood Advances

Publication Date

9-13-2022

Volume

6

Issue

17

First Page

4975

Last Page

4982

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2022007940

Rights and Permissions

Cuker A, Tseng EK, Schünemann HJ, Angchaisuksiri P, Blair C, Dane K, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo KM, Siegal DM, Skara M, Terrell DR, Touri K, Akl EA, Al Jabiri R, Al Jabiri Y, Boulos M, Brignardello-Petersen R, Charide R, Colunga-Lozano LE, Dearness K, Darzi AJ, Karam SG, Morgano GP, Morsi RZ, Philip BA, Benitez YR, Stevens A, Solo K, Wiercioch W, Mustafa RA, Nieuwlaat R. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Adv. 2022 Sep 13;6(17):4975-4982. doi: 10.1182/bloodadvances.2022007940 © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Cuker, Adam; Sanfilippo, Kristen M; and et al, "American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients." Blood Advances. 6, 17. 4975 - 4982. (2022).
https://digitalcommons.wustl.edu/oa_4/328